PMDA drug package insert
レナリドミドカプセル2.5mg「F」
PMDA Prescription drug · 富士製薬工業株式会社 · package insert Jun 26, 2026
Key facts
| Brand names | レナリドミドカプセル2.5mg「F」, レナリドミドカプセル5mg「F」 |
|---|---|
| Nonproprietary names | レナリドミド |
| Companies | 製造販売元（輸入）／富士製薬工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗造血器悪性腫瘍剤 |
| Therapeutic category codes | 874291 |
| YJ codes | 4291024M2047, 4291024M1040 |
| Approval numbers | 30500AMX00186, 30500AMX00187 |
| Package insert edition | 第5版 |
| Package insert date | Jun 26, 2026 |
| PMDA document key | 670109_4291024M1040_1 |
| PMDA company code | 670109 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: